Malignant neoplasm of cortex of adrenal gland
ICD-10 C74.0 is a billable code used to indicate a diagnosis of malignant neoplasm of cortex of adrenal gland.
C74.0 refers to a malignant neoplasm originating in the cortex of the adrenal gland, which is responsible for producing hormones such as cortisol, aldosterone, and androgens. These tumors can disrupt normal hormone production, leading to various endocrine disorders. Symptoms may include hypertension, weight gain, and abnormal glucose metabolism due to excess cortisol (Cushing's syndrome) or other hormonal imbalances. Diagnosis typically involves imaging studies such as CT or MRI scans, along with biochemical tests to assess hormone levels. Treatment often requires surgical intervention, and in some cases, adjunctive therapies like chemotherapy or radiation may be necessary. The prognosis can vary significantly based on tumor size, stage at diagnosis, and the presence of metastasis. Accurate coding is essential for proper treatment planning and reimbursement.
Detailed hormone level assessments, imaging results, and clinical symptoms.
Patients presenting with symptoms of Cushing's syndrome or adrenal insufficiency.
Ensure all hormonal assays and imaging studies are documented to support the diagnosis.
Pathology reports, staging information, and treatment plans.
Patients undergoing surgical resection of adrenal tumors or receiving chemotherapy.
Document the tumor's histological type and grade for accurate coding.
Performed for resection of malignant adrenal tumors.
Operative reports detailing the procedure and findings.
Endocrinologists and oncologists should ensure comprehensive documentation of the surgical approach and pathology.
Common symptoms include hypertension, weight gain, abnormal glucose metabolism, and signs of hormonal excess such as Cushing's syndrome.
Diagnosis typically involves imaging studies like CT or MRI, along with biochemical tests to assess hormone levels.
